| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > 4 Tips on How to Avoid Communication Lines Breakdown |
|
Main Subject - 4 Tips on How to Avoid Communication Lines Breakdown
For example, in a small, two-person company, there is often the greatest opportunity for direct conversation and discussion throug According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product hout the day. There are only two possibilities for verbal communication and it’s usually quick, easy and descriptive. If, however ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in a third member is added to the team, then six possible lines of communication are created - an increase of 300%. Direct communica lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ion becomes more difficult and often messages are interpreted (or misinterpreted) in a variety of different ways. Now, add a four here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe h team member and your communication possibilities increase to 12. A fifth person increases the possibilities to 20. That’s 20 di d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro fferent ways a message can be sent and interpreted. At this point a “communication failure” can occur. At a time when the company ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc should be focusing on growth and expansion, it is instead faced with confusion, misunderstanding and wasted time. Here are a few easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ips for avoiding the breakdowns that may occur when the lines of communication become overwhelming: * Periodically pull toget nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically er all members of the team. Choose one time to convey your message, new policies etc…. If possible, find a time when there are few and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ distractions, such as when machines are shut down or when the phones aren’t ringing. There is often a strong case to meet away fr ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi m the usual place of work. * If the message you plan to convey is long or complex, present it verbally, then distribute writt ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a n copies of the same statement. This technique increases retention and understanding substantially. * When there are at least dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod five team members, the company’s communications system becomes more formal and written communications - notes, reports, internal e cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin mails - become a part of daily operations. * When holding meetings, provide a quick review of what has transpired since the l tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen st meeting and what should be happening before the next one. The key to these meetings is that they be brief and held on a regular t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel basis. It may be worthwhile to keep simple notes along the lines of: 1 what was discussed 2 what is pending 3 ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust what should be followed up 4 items previous brought up that have been successfully handled 5 what sho y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products uld be brought up at the next meeting …… and why By having scheduled meetings, each team member knows that s/he will be briefed o . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de all company matters that pertain to them. The lines of communication remain intact and one clear message is received by all. In a elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip dition, people will feel a bigger part of the company and will invariably respond positively to the common goals/growth objectives tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:7 Steps to Business Communication Success The Qualities of A Professional
|